Cboe Global Markets
CBOE
281.57
+3.37
+1.21%
Cboe Global Markets
US · CBOE
#703 by market cap
Listed 1970
281.57
+3.37
+1.21%
Live - 5344 symbols - heartbeat 115s ago
· 2026-10-07 23:16
After-hours
280.99
-0.21%
Overnight
281.40
-0.06%
- Market cap
- 29.40B
- P/E (TTM)i
- 21.95
- P/Bi
- 5.23
- EPSi
- 10.42
- Div yieldi
- 1.02%
- 52W posi
- 39%
Reader sentiment
Are you bullish or bearish on CBOE?
Anonymous reader poll. Unscientific, not investment advice.
✦ Quant Financial Health how this is computed
Good
- Altman Z-Score is 6.08, above the 3.0 "safe zone" threshold.
- Most reliable for industrial/manufacturing companies; less meaningful for banks, insurers and other financials.
Revenue annual, last 8 years
Latest year +15.13% YoY
Margins
- Gross margin
- 40.90%
- Operating margin
- 32.12%
- Net margin
- 23.22%
Key ratios & quality
- Enterprise valuei
- 28.62B
- PEG ratioi
- 0.33
- Altman Z-Scorei
- 6.08
PEG uses trailing P/E against the 3-year net income growth rate (67.28%/yr) since forward earnings estimates aren't available here, so this is not a "forward PEG." Altman Z-Score below ~1.8 suggests financial distress risk, above ~3.0 suggests low risk; the model is most reliable for industrial/manufacturing companies and less meaningful for banks and other financial firms.
Income statement
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Revenue | 2.77B | 2.50B | 3.43B | 3.49B | 3.96B | 3.77B | 4.09B | 4.71B |
| Gross profit | 988.10M | 937.90M | 1.03B | 1.19B | 1.38B | 1.49B | 1.61B | 1.93B |
| Selling & admin expenses | 68.30M | 68.30M | 67.20M | 93.40M | 112.70M | 129.60M | 140.60M | 133.60M |
| Research & development | -- | -- | -- | -- | -- | -- | -- | -- |
| Operating profit | 629.40M | 585.70M | 707.40M | 821.50M | 970.40M | 1.07B | 1.18B | 1.51B |
| Pretax profit | 571.20M | 501.40M | 660.40M | 756.10M | 432.90M | 1.05B | 1.08B | 1.57B |
| Tax | 146.00M | 130.60M | 192.20M | 227.10M | 197.90M | 286.20M | 318.90M | 466.60M |
| Net profit | 425.20M | 370.80M | 468.20M | 529.00M | 235.00M | 761.40M | 764.90M | 1.10B |
| Basic EPS | 4 | 3 | 4 | 5 | 2 | 7 | 7 | 10 |
| Diluted EPS | 3.76 | 3.34 | 4.27 | 4.92 | 2.19 | 7.13 | 7.21 | 10.42 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Revenue | 1.20B | 1.17B | 1.14B | 1.20B | 1.27B | 1.44B |
| Gross profit | 449.00M | 459.40M | 476.30M | 543.60M | 601.00M | 576.90M |
| Selling & admin expenses | 27.20M | 24.80M | 33.60M | 39.80M | 26.30M | 22.40M |
| Research & development | -- | -- | -- | -- | -- | -- |
| Operating profit | 354.10M | 356.20M | 375.00M | 428.80M | 505.60M | 476.00M |
| Pretax profit | 350.20M | 334.60M | 430.10M | 451.70M | 515.50M | 494.70M |
| Tax | 99.60M | 99.50M | 129.30M | 138.20M | 129.80M | 141.60M |
| Net profit | 250.60M | 235.10M | 300.80M | 313.50M | 385.70M | 353.10M |
| Basic EPS | 2 | 2 | 3 | 3 | 4 | 3 |
| Diluted EPS | 2.37 | 2.23 | 2.85 | 2.97 | 3.66 | 3.35 |
Balance sheet
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Total current assets | 683.70M | 607.60M | 1.57B | 1.53B | 1.56B | 1.98B | 2.48B | 4.42B |
| Cash & ST investments | 310.80M | 300.30M | 337.80M | 379.00M | 524.40M | 600.70M | 1.03B | 2.25B |
| Inventory | -- | -- | -- | -- | -- | -- | -- | -- |
| Total assets | 5.32B | 5.11B | 6.52B | 6.81B | 7.00B | 7.49B | 7.79B | 9.31B |
| Total current liabilities | 595.90M | 281.60M | 1.31B | 1.17B | 1.48B | 1.38B | 1.40B | 2.36B |
| Short-term debt | 299.80M | -- | 68.70M | -- | 304.70M | 20.80M | 19.90M | 26.90M |
| Long-term debt | 915.60M | 867.60M | 1.14B | 1.30B | 1.44B | 1.44B | 1.44B | 1.44B |
| Total liabilities | 2,080,000,000.00 | 1,758,300,000.00 | 3,167,600,000.00 | 3,209,700,000.00 | 3,533,600,000.00 | 3,502,500,000.00 | 3,509,500,000.00 | 4,167,000,000.00 |
| Total equity | 3.24B | 3.36B | 3.35B | 3.60B | 3.47B | 3.99B | 4.28B | 5.14B |
| Retained earnings | 1.29B | 1.51B | 1.81B | 2.15B | 2.17B | 2.53B | 2.82B | 3.54B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Total current assets | 3.36B | 3.74B | 3.74B | 4.42B | 6.22B | 5.93B |
| Cash & ST investments | 1.15B | 1.46B | 1.53B | 2.25B | 2.17B | 2.39B |
| Inventory | -- | -- | -- | -- | -- | -- |
| Total assets | 8.67B | 9.05B | 9.07B | 9.31B | 11.07B | 10.61B |
| Total current liabilities | 2.10B | 2.39B | 2.18B | 2.36B | 4.49B | 3.79B |
| Short-term debt | 24.10M | 25.00M | 25.10M | 26.90M | 676.10M | 674.60M |
| Long-term debt | 1.44B | 1.44B | 1.44B | 1.44B | 793.90M | 794.20M |
| Total liabilities | 4,215,200,000.00 | 4,383,200,000.00 | 4,183,700,000.00 | 4,167,000,000.00 | 5,697,100,000.00 | 4,983,500,000.00 |
| Total equity | 4.45B | 4.67B | 4.88B | 5.14B | 5.37B | 5.63B |
| Retained earnings | 3.00B | 3.17B | 3.39B | 3.54B | 3.85B | 4.13B |
Cash flow
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | 534.70M | 632.80M | 1.46B | 596.80M | 651.10M | 1.08B | 1.10B | 1.75B |
| Depreciation & amortization | 204.00M | 176.60M | 158.50M | 167.40M | 166.80M | 158.00M | 133.00M | 122.40M |
| Free cash flow | 498.40M | 597.70M | 1.41B | 545.80M | 591.30M | 1.03B | 1.04B | 1.68B |
| Dividends paid | -130.30M | -150.00M | -170.60M | -193.30M | -209.40M | -223.50M | -249.40M | -284.30M |
| Stock buybacks / issuance | -140.90M | -156.90M | -349.10M | -81.30M | -100.90M | -83.90M | -204.80M | -66.70M |
| Ending cash balance | 275.10M | 229.30M | 1.06B | 1.09B | 979.90M | 1.40B | 1.77B | 3.87B |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| Operating cash flow | 912.90M | 333.70M | 153.90M | 352.10M | 1.96B | -503.20M |
| Depreciation & amortization | 30.30M | 29.90M | 30.90M | 31.30M | 29.50M | 28.10M |
| Free cash flow | 898.20M | 313.40M | 137.90M | 332.10M | 1.94B | -536.30M |
| Dividends paid | -66.40M | -66.40M | -75.70M | -75.80M | -75.80M | -75.70M |
| Stock buybacks / issuance | -30.00M | -36.70M | 0 | 0 | -40.90M | -34.40M |
| Ending cash balance | 2.67B | 2.96B | 3.17B | 3.87B | 5.61B | 4.92B |
Returns & efficiency
| Line item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| ROE %i | 13.29 | 11.30 | 13.93 | 15.17 | 6.62 | 20.33 | 18.42 | 23.25 |
| ROA %i | 7.97 | 7.14 | 8.03 | 7.91 | 3.39 | 10.46 | 9.96 | 12.81 |
| ROIC %i | 9.87 | 9.45 | 10.89 | 11.62 | 5.17 | 14.53 | 13.56 | 17.40 |
| 5-year avg ROE %i | 50.21 | 38.37 | 25.14 | 15.37 | 12.06 | 13.47 | 14.89 | 16.76 |
| EBIT margin %i | 22.03 | 21.54 | 20.30 | 23.01 | 12.45 | 29.42 | 27.73 | 34.34 |
| FCF / sales %i | 18.00 | 23.95 | 41.18 | 15.62 | 14.94 | 27.31 | 25.39 | 35.67 |
| Current ratioi | 1.15 | 2.16 | 1.19 | 1.31 | 1.05 | 1.43 | 1.78 | 1.87 |
| Quick ratioi | 1.12 | 2.10 | 0.55 | 0.64 | 0.64 | 0.73 | 1.11 | 1.15 |
| Debt / assetsi | 22.84 | 17.88 | 20.50 | 20.96 | 26.74 | 21.51 | 20.53 | 17.09 |
| LT debt / equityi | 28.25 | 27.25 | 37.84 | 39.63 | 45.21 | 39.90 | 36.91 | 30.43 |
| Interest coveragei | 15.76 | 14.85 | 19.71 | 16.75 | 8.22 | 17.79 | 22.04 | 30.95 |
| Revenue CAGR (3Y) %i | 60.97 | 52.55 | 15.42 | 8.07 | 16.62 | 3.26 | 5.42 | 6.00 |
| Net income CAGR (3Y) %i | 27.66 | 26.14 | 5.24 | 7.44 | -14.42 | 17.60 | 13.08 | 67.28 |
| FCF CAGR (3Y) %i | 34.25 | 47.78 | 61.21 | 3.07 | -0.36 | -9.95 | 23.96 | 41.68 |
| Line item | 2025-03 | 2025-06 | 2025-09 | 2025-12 | 2026-03 | 2026-06 |
|---|---|---|---|---|---|---|
| ROE %i | 18.93 | 20.64 | 21.52 | 23.25 | 25.03 | 26.19 |
| ROA %i | 9.54 | 9.79 | 11.00 | 12.81 | 12.46 | 13.71 |
| ROIC %i | 13.97 | 15.25 | 16.04 | 17.40 | 18.83 | 19.87 |
| 5-year avg ROE %i | -- | -- | -- | -- | -- | -- |
| EBIT margin %i | 27.54 | 29.24 | 31.32 | 34.34 | 37.24 | 38.43 |
| FCF / sales %i | 24.23 | -- | 13.32 | 35.67 | 56.85 | 37.04 |
| Current ratioi | 1.60 | 1.57 | 1.72 | 1.87 | 1.39 | 1.57 |
| Quick ratioi | 0.79 | 0.82 | 0.92 | 1.15 | 0.60 | 0.80 |
| Debt / assetsi | 18.50 | 17.69 | 17.58 | 17.09 | 14.31 | 14.90 |
| LT debt / equityi | 35.48 | 33.78 | 32.13 | 30.43 | 16.91 | 16.10 |
| Interest coveragei | 23.26 | 25.78 | 27.87 | 30.95 | 33.80 | 36.63 |
| Revenue CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| Net income CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
| FCF CAGR (3Y) %i | -- | -- | -- | -- | -- | -- |
✦ Quant Revenue Concentration how this is computed
Lead segment, long tail
- Options is the largest reported line at 51.50% of revenue, across 5 reported segments.
- North American Equities follows at 36.04%, so the top line still matters most but isn’t the whole story.
Revenue breakdown most recent period
Business
Options51.50%
North American Equities36.04%
Europe and Asia Pacific8.16%
Futures2.31%
Global FX1.98%
Quote time 2026-10-07 23:16:38 · For reference only, not investment advice and not tailored to your situation.